Developed by a team led by Dr. Stuart English, the Sleep Mask is a revolutionary prototype that works using light-emitting diodes (LEDs) to effectively treat diabetic retinopathy, which can lead to sight loss in time.
Explaining the project and the benefits therein, Dr. English says, "The product we have developed with PolyPhotonix is a treatment for macular eye disease that is non-invasive, saving lots of money over existing treatments such as using lasers and injections into the eye." While still in development, the Sleep Mask is something of a godsend when compared against current projections regarding worldwide diabetes rates, which are set to go up a whopping 50% within the 2010 to 2030 year range.
The Sleep Mask could become one of the leading treatments for macular eye disease if it indeed offers an effective way to treat the ailment.
Key Themes Behind This Trend
- Diabetic Retinopathy Treatment
- The Sleep Mask's use of LEDs to treat diabetic retinopathy presents a disruptive innovation opportunity for the eye healthcare industry.
- Non-invasive Eye Disease Treatment
- The development of the Sleep Mask as a non-invasive treatment for macular eye disease opens up disruptive innovation opportunities in the healthcare industry.
- Led-based Therapies
- The use of light-emitting diodes (LEDs) in the Sleep Mask's treatment for sight loss presents a disruptive innovation opportunity for the LED technology industry.
Where This Applies
- Eye Healthcare
- The Sleep Mask's potential as a leading treatment for macular eye disease creates disruptive innovation opportunities within the eye healthcare industry.
- Healthcare
- The development of non-invasive treatments like the Sleep Mask opens up disruptive innovation opportunities within the healthcare industry as a whole.
- LED Technology
- The application of LEDs in the Sleep Mask's therapy for sight loss presents disruptive innovation opportunities within the LED technology industry.
